Morgan Stanley Maintains Underweight on Virtus Inv, Raises Price Target to $217

Benzinga · 10/18 13:08
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and raises the price target from $208 to $217.